Inactive Instrument

Coland Holdings Limited

4144

KYG2379A1094

Coland Holdings Limited Announces Cash Dividend

July 22, 2020 at 04:05 am EDT

Coland Holdings Limited announced cash dividend of RMB 30,000,000.

Latest news about Coland Holdings Limited

Coland Holdings Limited Announces the Financial Supervisory Commission Approval of the Termination of the Its Public Company Status Since October 30, 2020	20-10-13	CI
Coland Holdings Limited Reports Impairment of Assets for the Second Quarter of 2020	20-08-13	CI
Coland Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Oceanic World Sub Corp entered into Letter of Intent to acquire Coland Holdings Limited for TWD 2 billion.	20-07-26	CI
Golden Hexagon Investments Limited made a tender offer to acquire an additional 15% stake in Coland Holdings Limited for approximately TWD 310 million.	20-06-10	CI
Coland Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-11	CI
Coland Holdings Limited Announces the Appointment of Tsao Johua as Company's New Head of Company Secretary	20-03-18	CI
Coland Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-17	CI
Coland Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-13	CI
Coland Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-13	CI
Coland Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-12	CI
Coland Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2018	19-02-24	CI
Coland Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018; Reports Impairment Charges for the Third Quarter of 2018	18-11-13	CI
Coland Holdings Limited announced that it expects to receive TWD 405 million in funding	18-08-19	CI
Coland Holdings Seeks Acquisitions	18-04-27	CI
Coland Holdings Limited announced that it expects to receive TWD 250 million in funding	18-04-26	CI
An unknown buyer cancelled the acquisition of Revlis Biotech Co., Ltd. from Coland Holdings Limited.	18-03-23	CI
An unknown buyer cancelled the acquisition of CDIB Healthcare Fund Ltd. from Coland Holdings Limited.	18-03-23	CI
The transaction has been cancelled as per closing tool guideline.	18-03-23	CI
Coland Holdings Limited Reports Earnings Results for the Month of February 2018, Fourth Quarter of 2017 and Full Year 2017	18-03-23	CI
An unknown buyer agreed to acquire Hung Chun Bio-S Tech Co., Ltd. from Coland Holdings Limited for TWD 82.9 million.	17-03-23	CI
An unknown buyer agreed to acquire Revlis Biotech Co., Ltd. from Coland Holdings Limited for TWD 70 million.	17-03-23	CI
An unknown buyer agreed to acquire CDIB Healthcare Fund Ltd. from Coland Holdings Limited for TWD 30 million.	17-03-23	CI
Coland Holdings Limited Announces Resignation of Lee Hsin as Director	16-12-29	CI
Coland Holdings Limited(TSEC:4144) dropped from S&P Global BMI Index	16-09-19	CI

Coland Holdings Limited is a Taiwan-based company principally engaged in the development and distribution of pharmaceuticals. The Company provides products for the treatment of hepatitis, respiratory system diseases, urinary systems, cardiovascular and nervous system diseases. The Company also offers medical equipment, spinal instrumentations and antibiotics. Its products include Adefovir Dipivoxil Tablets, Mycophenolate Mofetil Dispersible Tablets, Tiotropium Bromide Powder For Inhalation, Amoxicillin Sodium and Clavulanate Potassium for Injection and Lamivudine Tablets. The Company operates its businesses primarily in Mainland China.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.18B
OTSUKA HOLDINGS CO., LTD.	+24.05%	23.23B
SANDOZ GROUP AG	+15.11%	14.6B
CIPLA LIMITED	+12.33%	13.54B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-7.63%	6.79B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.31B

Generic Pharmaceuticals